Proton beam may spare healthy brain tissue in young tumor patients
NCT ID NCT01049230
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study is testing whether proton beam radiation can effectively treat germ cell tumors in the brain while causing fewer side effects than standard photon radiation. About 45 participants aged 3 to 25 will receive daily proton radiation for 4 to 8 weeks. Researchers will track side effects and how long the tumor stays under control.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Proton beam radiation
- What this could lead to
- If successful, this could show that proton radiation is a safer way to treat brain germ cell tumors with fewer long-term side effects than standard radiation.
- What could go wrong
- This is a small, early-phase study with only 45 participants, so results may not apply to everyone. The treatment still carries risks of radiation side effects, and it is not a cure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL NERVOUS SYSTEM GERM CELL TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02115, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- High-Dose chemo with stem cell transplant tested against standard therapy for tough germ cell cancers
- Could a dementia drug shield kids' brains from radiation damage?
- Dietary change explored as cancer support strategy
- Hypnosis may ease chemo anxiety in teens and young adults
- Could a simple pill keep relapsed testicular cancer at bay?
- Experimental drug cocktail aims to outsmart childhood cancers